These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28209189)

  • 21. Cost of noninfectious comorbidities in patients with HIV.
    Guaraldi G; Zona S; Menozzi M; Carli F; Bagni P; Berti A; Rossi E; Orlando G; Zoboli G; Palella F
    Clinicoecon Outcomes Res; 2013 Sep; 5():481-8. PubMed ID: 24098086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What's pregnancy got to do with it? Late presentation to HIV/AIDS services in Northeastern Brazil.
    Dourado I; MacCarthy S; Lima C; Veras MA; Kerr L; de Brito AM; Gruskin S
    AIDS Care; 2014; 26(12):1514-20. PubMed ID: 25033205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating minimum adult HIV prevalence: a cross-sectional study to assess the characteristics of people living with HIV in Italy.
    Camoni L; Raimondo M; Dorrucci M; Regine V; Salfa MC; Suligoi B;
    AIDS Res Hum Retroviruses; 2015 Mar; 31(3):282-7. PubMed ID: 25432098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late presentation to HIV/AIDS care at the Douala general hospital, Cameroon: its associated factors, and consequences.
    Luma HN; Jua P; Donfack OT; Kamdem F; Ngouadjeu E; Mbatchou HB; Doualla MS; Mapoure YN
    BMC Infect Dis; 2018 Jul; 18(1):298. PubMed ID: 29970017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late presentation to HIV/AIDS care in Brazil among men who self-identify as heterosexual.
    MacCarthy S; Brignol S; Reddy M; Nunn A; Dourado I
    Rev Saude Publica; 2016 Aug; 50():54. PubMed ID: 27556968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comorbidities and costs in HIV patients: A retrospective claims database analysis in Germany.
    Christensen S; Wolf E; Altevers J; Diaz-Cuervo H
    PLoS One; 2019; 14(11):e0224279. PubMed ID: 31693696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune status at presentation to care did not improve among antiretroviral-naive persons from 1990 to 2006.
    Keruly JC; Moore RD
    Clin Infect Dis; 2007 Nov; 45(10):1369-74. PubMed ID: 17968837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity?
    Goulet JL; Fultz SL; Rimland D; Butt A; Gibert C; Rodriguez-Barradas M; Bryant K; Justice AC
    Clin Infect Dis; 2007 Dec; 45(12):1593-601. PubMed ID: 18190322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late presentation for human immunodeficiency virus HIV diagnosis results of a Belgian single centre.
    Yombi JC; Jonckheere S; Vincent A; Wilmes D; Vandercam B; Belkhir L
    Acta Clin Belg; 2014; 69(1):33-9. PubMed ID: 24635397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of late presentation and advanced HIV disease among people living with HIV in Oman (2000-2019).
    Elgalib A; Shah S; Al-Wahaibi A; Al-Habsi Z; Al-Fouri M; Lau R; Al-Kindi H; Al-Rawahi B; Al-Abri S
    BMC Public Health; 2021 Nov; 21(1):2029. PubMed ID: 34742286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late Presentation into Care of HIV Disease and Its Associated Factors in Asia: Results of TAHOD.
    Jeong SJ; Italiano C; Chaiwarith R; Ng OT; Vanar S; Jiamsakul A; Saphonn V; Nguyen KV; Kiertiburanakul S; Lee MP; Merati TP; Pham TT; Yunihastuti E; Ditangco R; Kumarasamy N; Zhang F; Wong W; Sim BL; Pujari S; Kantipong P; Phanuphak P; Ratanasuwan W; Oka S; Mustafa M; Durier N; Choi JY
    AIDS Res Hum Retroviruses; 2016 Mar; 32(3):255-61. PubMed ID: 26414065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients.
    Orlando G; Meraviglia P; Cordier L; Meroni L; Landonio S; Giorgi R; Fasolo M; Faggion I; Riva A; Zambelli A; Beretta R; Gubertini G; Dedivitiis G; Jacchetti G; Cargnel A
    HIV Med; 2006 Nov; 7(8):549-57. PubMed ID: 17105515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of late presentation for HIV treatment in a reference center in Belo Horizonte, Southeastern Brazil, from 2008 to 2010.
    Valentini MB; Toledo ML; Fonseca MO; Thiersch LM; Toledo IS; Machado FC; Tupinambás U
    Braz J Infect Dis; 2015; 19(3):253-62. PubMed ID: 25769736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cost of Illness of HIV Patients under Anteretroviral Therapy in Germany - Results of the 48-Week Interim Analysis of the Prospective Multicentre Observational Study 'CORSAR'].
    Kuhlmann A; Mittendorf T; Hower M; Heiken H; Gerschmann S; Klauke S; Lutz T; Bogner J; Degen O; van Lunzen J; Bachmann C; Stellbrink HJ; Schmidt W; Leistner I; Mahlich J; Ranneberg B; Stoll M
    Gesundheitswesen; 2015 Jun; 77(6):e133-42. PubMed ID: 25247761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa.
    Larson BA; Rockers PC; Bonawitz R; Sriruttan C; Glencross DK; Cassim N; Coetzee LM; Greene GS; Chiller TM; Vallabhaneni S; Long L; van Rensburg C; Govender NP
    PLoS One; 2016; 11(7):e0158986. PubMed ID: 27390864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic burden of late presentation in HIV disease in Austria: a comparison of the initial costs imposed by advanced HIV disease vs. non-late presentation.
    Grabmeier-Pfistershammer K; Rieger A; Schröck T; Schlag M
    Wien Klin Wochenschr; 2013 Jul; 125(13-14):402-7. PubMed ID: 23807043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).
    Mocroft A; Lundgren JD; Sabin ML; Monforte Ad; Brockmeyer N; Casabona J; Castagna A; Costagliola D; Dabis F; De Wit S; Fätkenheuer G; Furrer H; Johnson AM; Lazanas MK; Leport C; Moreno S; Obel N; Post FA; Reekie J; Reiss P; Sabin C; Skaletz-Rorowski A; Suarez-Lozano I; Torti C; Warszawski J; Zangerle R; Fabre-Colin C; Kjaer J; Chene G; Grarup J; Kirk O;
    PLoS Med; 2013; 10(9):e1001510. PubMed ID: 24137103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost of medical care for HIV-infected patients within a regional population from 1997 to 2006.
    Krentz HB; Gill MJ
    HIV Med; 2008 Oct; 9(9):721-30. PubMed ID: 18643856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comorbidities in people living with HIV: An epidemiologic and economic analysis using a claims database in France.
    Pourcher V; Gourmelen J; Bureau I; Bouee S
    PLoS One; 2020; 15(12):e0243529. PubMed ID: 33332394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting CD4 testing to a clinical subgroup of patients could limit unnecessary CD4 measurements, premature antiretroviral treatment and costs in Thyolo District, Malawi.
    Zachariah R; Teck R; Ascurra O; Humblet P; Harries AD
    Trans R Soc Trop Med Hyg; 2006 Jan; 100(1):24-31. PubMed ID: 16202436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.